{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:26:59Z","timestamp":1793831219268,"version":"4.6.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004204","name":"Tongji University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004204","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bcp.2020.114114","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T01:32:52Z","timestamp":1592703172000},"page":"114114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management"],"prefix":"10.1016","volume":"178","author":[{"given":"Lin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aislinn M.","family":"O'Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaguang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmara","family":"Motriuk-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10225","key":"10.1016\/j.bcp.2020.114114_b0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"issue":"10224","key":"10.1016\/j.bcp.2020.114114_b0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcp.2020.114114_b0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/resp.13196","article-title":"MERS, SARS and other coronaviruses as causes of pneumonia","volume":"23","author":"Yin","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.bcp.2020.114114_b0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijid.2020.02.033","article-title":"Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: a data-driven analysis","volume":"93","author":"Zhang","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"10223","key":"10.1016\/j.bcp.2020.114114_b0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bcp.2020.114114_b0030","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"10223","key":"10.1016\/j.bcp.2020.114114_b0035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"964","key":"10.1016\/j.bcp.2020.114114_b0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/pgmj.2005.037515","article-title":"Cardiovascular complications of severe acute respiratory syndrome","volume":"82","author":"Yu","year":"2006","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.bcp.2020.114114_b0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","article-title":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","volume":"49","author":"Badawi","year":"2016","journal-title":"Int. J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.bcp.2020.114114_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2015.11.006","article-title":"Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins","volume":"129","author":"Sarkisian","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bcp.2020.114114_b0055","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"C. China Medical Treatment Expert Group for, Clinical Characteristics of Coronavirus Disease 2019 in China","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2020.114114_b0060","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","author":"Li","year":"2020","journal-title":"Clin. Res. Cardiol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114114_b0065","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1038\/s41598-017-09536-z","article-title":"Altered Lipid metabolism in recovered SARS patients twelve years after infection","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2020.114114_b0070","article-title":"Association Between hospitalization for pneumonia and subsequent risk of cardiovascular disease (vol 313, pg 264, 2015)","volume":"313","author":"Corrales-Medina","year":"2015","journal-title":"Jama-J. Ame. Med. Assoc."},{"issue":"1","key":"10.1016\/j.bcp.2020.114114_b0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jinf.2006.01.005","article-title":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong","volume":"54","author":"Yam","year":"2007","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.bcp.2020.114114_b0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5144\/0256-4947.2016.78","article-title":"Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus","volume":"36","author":"Alhogbani","year":"2016","journal-title":"Ann. Saudi Med."},{"issue":"3","key":"10.1016\/j.bcp.2020.114114_b0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2020.114114_b0090","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1828","article-title":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock","author":"Tavazzi","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bcp.2020.114114_b0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac Involvement in a patient with coronavirus disease 2019 (COVID-19)","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bcp.2020.114114_b0100","article-title":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin","author":"Hu","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2020.114114_b0105","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.bcp.2020.114114_b0110","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","author":"Liu","year":"2020","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.bcp.2020.114114_b0115","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202003-0543OC","article-title":"Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study","author":"Du","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bcp.2020.114114_b0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bcp.2020.114114_b0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","author":"Duan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10223","key":"10.1016\/j.bcp.2020.114114_b0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2020.114114_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","author":"Yang","year":"2020","journal-title":"Lancet Respiratory Med."},{"key":"10.1016\/j.bcp.2020.114114_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.resuscitation.2020.04.005","article-title":"In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China","author":"Shao","year":"2020","journal-title":"Resuscitation"},{"key":"10.1016\/j.bcp.2020.114114_b0145","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2020.114114_b0150","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic","author":"Driggin","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10229","key":"10.1016\/j.bcp.2020.114114_b0155","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcp.2020.114114_b0160","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1055\/s-0040-1712926","article-title":"Heart failure with preserved ejection fraction in a postpartum patient with superimposed preeclampsia and COVID-19","volume":"10","author":"Sinkey","year":"2020","journal-title":"AJP Rep."},{"issue":"6","key":"10.1016\/j.bcp.2020.114114_b0165","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10741-017-9644-1","article-title":"Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease","volume":"22","author":"Patel","year":"2017","journal-title":"Heart Fail. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2020.114114_b0170","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thrombosis Haemostasis: JTH"},{"key":"10.1016\/j.bcp.2020.114114_b0175","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.047430","article-title":"Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence","author":"Poissy","year":"2020","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.bcp.2020.114114_b0180","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/eurheartj\/ehaa254","article-title":"Acute pulmonary embolism and COVID-19 pneumonia: a random association?","volume":"41","author":"Danzi","year":"2020","journal-title":"Eur. Heart J."},{"issue":"10234","key":"10.1016\/j.bcp.2020.114114_b0185","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.bcp.2020.114114_b0190","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"Right ventricular, COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. College Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114114_b0195","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.bcp.2020.114114_b0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: from vasopeptidase to SARS virus receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"14","key":"10.1016\/j.bcp.2020.114114_b0205","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.CIR.0000094734.67990.99","article-title":"Increased angiotensin-(1\u20137)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2","volume":"108","author":"Zisman","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bcp.2020.114114_b0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.toxlet.2010.08.021","article-title":"Angiotensin-(1\u20137) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: role of MMPs\/TIMPs","volume":"199","author":"Pei","year":"2010","journal-title":"Toxicol. Lett."},{"issue":"3 Pt 2","key":"10.1016\/j.bcp.2020.114114_b0215","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.HYP.30.3.535","article-title":"Counterregulatory actions of angiotensin-(1\u20137)","volume":"30","author":"Ferrario","year":"1997","journal-title":"Hypertension"},{"issue":"6891","key":"10.1016\/j.bcp.2020.114114_b0220","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2020.114114_b0225","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2020.114114_b0230","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.bcp.2020.114114_b0235","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijid.2020.05.002","article-title":"Urgent need for evaluating agonists of angiotensin-(1\u20137)\/Mas receptor axis for treating patients with COVID-19","volume":"96","author":"Shete","year":"2020","journal-title":"Int. J. Infectious Dis."},{"issue":"21","key":"10.1016\/j.bcp.2020.114114_b0240","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1161\/CIRCULATIONAHA.120.047297","article-title":"Substituting angiotensin-(1\u20137) to prevent lung damage in SARS-CoV-2 infection?","volume":"141","author":"Peiro","year":"2020","journal-title":"Circulation"},{"issue":"6965","key":"10.1016\/j.bcp.2020.114114_b0245","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114114_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2020.114114_b0255","first-page":"419","article-title":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia","volume":"31","author":"Henry","year":"2018","journal-title":"Proc (Bayl. Univ. Med. Cent.)"},{"issue":"7047","key":"10.1016\/j.bcp.2020.114114_b0260","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114114_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bcp.2020.114114_b0270","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2020.114114_b0275","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China","author":"Li","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bcp.2020.114114_b0280","unstructured":"ESH, ESH UPDATE ON COVID-19: Statement of the European Society of Hypertension (ESH) on hypertension, Renin Angiotensin System blockers and COVID-19, 2020. https:\/\/www.eshonline.org\/spotlights\/esh-stabtement-on-covid-19\/."},{"key":"10.1016\/j.bcp.2020.114114_b0285","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","author":"Pedersen","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2020.114114_b0290","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev.: MMBR"},{"issue":"1","key":"10.1016\/j.bcp.2020.114114_b0295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","article-title":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome","volume":"136","author":"Wong","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2020.114114_b0300","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/jir.2011.0057","article-title":"Critical cytokine pathways to cardiac inflammation","volume":"31","author":"Rose","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bcp.2020.114114_b0305","unstructured":"B. Kaplan, C. Sulentic, H. Haggerty, M. Holsapple, N. Kaminski, Toxic Responses of the Immune System. In Barnes and Davis (Eds). Toxicology (Ch 12). New York: McGraw Hill Education."},{"key":"10.1016\/j.bcp.2020.114114_b0310","unstructured":"P. Belluck, 'Straight-Up Fire' in His Veins: Teen Battles New COVID Syndrome, 2020. https:\/\/www.yahoo.com\/news\/straight-fire-veins-teen-battles-122647600.html."},{"issue":"7","key":"10.1016\/j.bcp.2020.114114_b0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bcp.2020.114114_b0320","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/689360","article-title":"The Renin-Angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int. J. Inflammation"},{"issue":"11","key":"10.1016\/j.bcp.2020.114114_b0325","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1681\/ASN.2006040356","article-title":"Renin-angiotensin-aldosterone system and progression of renal disease","volume":"17","author":"Ruster","year":"2006","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10.1016\/j.bcp.2020.114114_b0330","doi-asserted-by":"crossref","unstructured":"S. Richardson, J.S. Hirsch, M. Narasimhan, J.M. Crawford, T. McGinn, K.W. Davidson, C.-R.C. and the Northwell, D.P. Barnaby, L.B. Becker, J.D. Chelico, S.L. Cohen, J. Cookingham, K. Coppa, M.A. Diefenbach, A.J. Dominello, J. Duer-Hefele, L. Falzon, J. Gitlin, N. Hajizadeh, T.G. Harvin, D.A. Hirschwerk, E.J. Kim, Z.M. Kozel, L.M. Marrast, J.N. Mogavero, G.A. Osorio, M. Qiu, T.P. Zanos, Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area, Jama (2020).","DOI":"10.1001\/jama.2020.6775"},{"key":"10.1016\/j.bcp.2020.114114_b0335","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.3633","article-title":"Care for critically Ill patients with COVID-19","author":"Murthy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2020.114114_b0340","unstructured":"M. Brunsvold, ECMO and COVID., University of Minnesota (2020)."},{"issue":"1","key":"10.1016\/j.bcp.2020.114114_b0345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2020.114114_b0350","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/bcp.12075","article-title":"Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects","volume":"76","author":"Mueck","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"24","key":"10.1016\/j.bcp.2020.114114_b0355","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"Controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2020.114114_b0360","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: from malaria to autoimmunity","volume":"42","author":"Ben-Zvi","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114114_b0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000094079","article-title":"Cardiomyopathy related to antimalarial therapy with illustrative case report","volume":"107","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Cardiology"},{"key":"10.1016\/j.bcp.2020.114114_b0370","first-page":"1057","article-title":"The impact of stress on body function: a review","volume":"16","author":"Yaribeygi","year":"2017","journal-title":"EXCLI J."},{"issue":"16","key":"10.1016\/j.bcp.2020.114114_b0375","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/01.CIR.99.16.2192","article-title":"Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy","volume":"99","author":"Rozanski","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2020.114114_b0380","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25798","article-title":"Novel coronavirus treatment with ribavirin: groundwork for an evaluation concerning COVID-19","author":"Khalili","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bcp.2020.114114_b0385","article-title":"Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: an evaluation of the evidence","volume":"101647","author":"Cao","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"issue":"5","key":"10.1016\/j.bcp.2020.114114_b0390","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Morse","year":"2020","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bcp.2020.114114_b0395","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.bcp.2020.114114_b0400","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.bcp.2020.114114_b0405","unstructured":"Lexi-Drugs., Lexi-Comp OnlineTM. Hudson (OH): Wolters Kluwer Clinical Drug Information, Inc.; 2020. Available from: http:\/\/online.lexi.com."},{"issue":"1","key":"10.1016\/j.bcp.2020.114114_b0410","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2020.114114_b0415","first-page":"170","article-title":"Potential antiviral therapeutics for 2019 Novel Coronavirus","volume":"43","author":"Li","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.bcp.2020.114114_b0420","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10225","key":"10.1016\/j.bcp.2020.114114_b0425","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(20)30361-5","article-title":"On the use of corticosteroids for 2019-nCoV pneumonia","volume":"395","author":"Shang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2020.114114_b0430","unstructured":"K. Glynn, University of Minnesota Launches COVID-19 Clinical Trials of Blood Pressure Drug Losartan. University of Minnesota Medical School. 2020 https:\/\/med.umn.edu\/news-events\/university-minnesota-launches-covid-19-clinical-trials-blood-pressure-drug-losarta, (2020)."},{"key":"10.1016\/j.bcp.2020.114114_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.03.039","article-title":"Treatment with convalescent plasma for critically Ill patients with SARS-CoV-2 infection","author":"Zhang","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.bcp.2020.114114_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.02.016","article-title":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang China","author":"Yang","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.bcp.2020.114114_b0445","doi-asserted-by":"crossref","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.bcp.2020.114114_b0450","article-title":"Clinical characteristics of imported cases of COVID-19 in Jiangsu Province: a multicenter descriptive study","author":"Wu","year":"2020","journal-title":"Clin. Infect. Dis."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:07:28Z","timestamp":1762096048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220303506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":90,"alternative-id":["S0006295220303506"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114114","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114114"}}